| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$140.00
Est. +23%
|
$114.12 | $117.00 |
Pending
|
$110.34
-3.3%
|
| Jul 13, 2026 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$34.00
Est. +47%
|
$23.06 | $24.03 |
Pending
|
$23.60
+2.3%
|
| Jul 13, 2026 |
Spyre Therapeutics Inc.
SYRE
|
BUY |
$120.00
Est. +23%
|
$97.74 | $105.09 |
Pending
|
$99.17
+1.5%
|
| Jun 24, 2026 |
Apogee Therapeutics Inc.
APGE
|
BUY |
$135.00
Est. +2%
|
$132.88 | $134.40 |
Bullseye Hit (±1%)
|
$134.08
+0.9%
|
| Jun 08, 2026 |
Tango Therapeutics Inc
TNGX
|
BUY |
$36.00
Est. +16%
|
$31.08 | $33.53 |
Pending
|
$28.10
-9.6%
|
| May 22, 2026 |
Q32 Bio Inc.
QTTB
|
BUY |
$14.00
Est. +155%
|
$5.50 | $23.57 |
Target Met
|
$15.08
+174.2%
|
| May 15, 2026 |
Tango Therapeutics Inc
TNGX
|
BUY |
$30.00
Est. +21%
|
$24.87 | $33.53 |
Target Met
|
$28.10
+13.0%
|
| Dec 17, 2025 |
Bicara Therapeutics Inc. Common Stock
BCAX
|
BUY |
$18.00
Est. +0%
|
$17.98 | $30.93 |
Target Met
|
$27.96
+55.5%
|
| Dec 17, 2025 |
Avalo Therapeutics Inc
AVTX
|
BUY |
$39.00
Est. +103%
|
$19.25 | $24.25 |
Pending
|
$18.15
-5.7%
|
| Jan 31, 2025 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$7.50
Est. +28%
|
$5.85 | $6.16 |
Miss
|
$5.17
-11.6%
|
| Nov 15, 2024 |
Halozyme Therapeutics Inc.
HALO
|
BUY |
$52.00
Est. +11%
|
$46.72 | $79.50 |
Target Met
|
$77.82
+66.6%
|
| Nov 08, 2024 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$3.25
Est. +198%
|
$1.09 | $4.62 |
Target Met
|
$3.33
+205.5%
|
| Nov 07, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$105.00
Est. +17%
|
$90.09 | $124.61 |
Target Met
|
$130.34
+44.7%
|
| Nov 07, 2024 |
Revolution Medicines Inc
RVMD
|
BUY |
$70.00
Est. +25%
|
$56.09 | $63.15 |
Miss
|
$182.96
+226.2%
|
| Nov 04, 2024 |
Essa Pharma Inc
EPIX
|
BUY |
$2.00
Est. +23%
|
$1.63 | $1.95 |
Precision Hit (±3%)
|
$0.20
-87.7%
|
| Oct 31, 2024 |
Biomea Fusion Inc
BMEA
|
BUY |
$19.00
Est. +84%
|
$10.34 | $10.80 |
Miss
|
$1.29
-87.5%
|
| Oct 30, 2024 |
Exelixis Inc
EXEL
|
BUY |
$36.00
Est. +25%
|
$28.73 | $49.40 |
Target Met
|
$54.98
+91.4%
|
| Sep 27, 2024 |
Biomea Fusion Inc
BMEA
|
BUY |
$10.00
Est. +1%
|
$9.90 | $13.07 |
Target Met
|
$1.29
-87.0%
|
| Sep 17, 2024 |
Revolution Medicines Inc
RVMD
|
BUY |
$57.00
Est. +29%
|
$44.24 | $62.40 |
Target Met
|
$182.96
+313.6%
|
| Sep 17, 2024 |
Tango Therapeutics Inc
TNGX
|
BUY |
$18.00
Est. +101%
|
$8.97 | $9.84 |
Miss
|
$28.10
+213.3%
|
| Sep 11, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$95.00
Est. +19%
|
$79.93 | $121.83 |
Target Met
|
$130.34
+63.1%
|
| Aug 27, 2024 |
Aadi Bioscience Inc
AADI
|
BUY |
$1.75
Est. 0%
|
$1.75 | $3.81 |
Target Met
|
$2.05
+17.1%
|
| Aug 15, 2024 |
LENZ Therapeutics Inc.
LENZ
|
BUY |
$36.00
Est. +62%
|
$22.25 | $41.70 |
Target Met
|
$5.34
-76.0%
|
| Jul 29, 2024 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$10.00
Est. +8%
|
$9.25 | $12.50 |
Target Met
|
$5.17
-44.1%
|
| Jun 18, 2024 |
Keros Therapeutics Inc
KROS
|
BUY |
$105.00
Est. +135%
|
$44.65 | $72.37 |
Miss
|
$10.21
-77.1%
|
| Jun 07, 2024 |
Halozyme Therapeutics Inc.
HALO
|
SELL |
$51.00
Est. +1%
|
$51.44 | $42.01 (Low) |
Target Met
|
$77.82
-51.3%
|
| May 27, 2024 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$3.50
Est. +100%
|
$1.75 | $2.55 |
Miss
|
$3.33
+90.3%
|
| May 16, 2024 |
Context Therapeutics Inc
CNTX
|
BUY |
$4.50
Est. +166%
|
$1.69 | $2.73 |
Miss
|
$0.61
-63.7%
|
| Apr 25, 2024 |
Acrivon Therapeutics Inc
ACRV
|
BUY |
$30.00
Est. +226%
|
$9.20 | $10.16 |
Miss
|
$1.68
-81.7%
|
| Apr 04, 2024 |
Achilles Therapeutics Plc - ADR
ACHL
|
BUY |
$2.00
Est. +122%
|
$0.90 | $1.51 |
Miss
|
$1.48
+64.4%
|
| Mar 14, 2024 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$19.00
Est. +34%
|
$14.21 | $12.50 |
Miss
|
$5.17
-63.6%
|
| May 03, 2023 |
Immunogen, Inc.
IMGN
|
BUY |
$16.00
Est. +31%
|
$12.26 | $31.25 |
Target Met
|
$31.24
+154.8%
|
| Jan 08, 2023 |
Day One Biopharmaceuticals Inc
DAWN
|
BUY |
$45.00
Est. +111%
|
$21.34 | - | - |
$21.53
+0.9%
|
| Dec 19, 2022 |
Catalyst Pharmaceuticals Inc
CPRX
|
BUY |
$20.00
Est. +22%
|
$16.41 | - | - |
$31.49
+91.9%
|
| Dec 11, 2022 |
Acrivon Therapeutics Inc
ACRV
|
BUY |
$25.00
Est. +100%
|
$12.50 | - | - |
$1.68
-86.6%
|
| Nov 20, 2022 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$11.00
Est. +66%
|
$6.62 | - | - |
$5.17
-21.9%
|
| Aug 10, 2022 |
Harpoon Therapeutics Inc
HARP
|
SELL |
$7.00
Est. +97%
|
$216.00 | - | - |
$23.01
+89.3%
|
| Jun 20, 2022 |
Day One Biopharmaceuticals Inc
DAWN
|
BUY |
$40.00
Est. +153%
|
$15.79 | - | - |
$21.53
+36.4%
|
| Jun 20, 2022 |
Repare Therapeutics Inc
RPTX
|
BUY |
$30.00
Est. +126%
|
$13.27 | - | - |
$2.65
-80.0%
|
| Jun 07, 2022 |
Ocular Therapeutix Inc
OCUL
|
BUY |
$10.00
Est. +165%
|
$3.78 | - | - |
$8.59
+127.1%
|
| May 18, 2022 |
Keros Therapeutics Inc
KROS
|
BUY |
$120.00
Est. +201%
|
$39.92 | - | - |
$10.21
-74.4%
|
| May 05, 2022 |
Connect Biopharma Holdings Ltd - ADR
CNTB
|
BUY |
$1.50
Est. +83%
|
$0.82 | - | - |
$2.20
+168.3%
|
| Dec 17, 2021 |
Global Blood Therapeutics Inc.
GBT
|
BUY |
$40.00
Est. +31%
|
$30.55 | $68.49 |
Target Met
|
$68.49
+124.2%
|
| Nov 30, 2021 |
Immunogen, Inc.
IMGN
|
BUY |
$6.50
Est. +5%
|
$6.17 | - | - |
$31.24
+406.2%
|